CXM (CXM) insider plans sale of 21,665 common shares on NYSE
Rhea-AI Filing Summary
An individual shareholder of CXM has filed a notice of proposed sale for up to 21,665 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 157,071.25. The issuer has 145,436,454 common shares outstanding, which is a baseline figure for the company’s total equity.
The filing shows that 8,997 shares were acquired on 12/15/2021 through an employee stock purchase plan for cash, and 12,668 shares were acquired on 12/15/2025 as restricted stock units. It also notes that Jacob Scott, based in New York, sold 9,942 shares of common stock in the past three months, generating gross proceeds of 77,348.76. The seller represents that they are not aware of undisclosed material adverse information about CXM when signing this notice.
Positive
- None.
Negative
- None.
FAQ
What does CXM's Form 144 filing disclose?
The filing discloses a planned sale under Rule 144 of up to 21,665 shares of CXM common stock through Morgan Stanley Smith Barney LLC on the NYSE, along with details on how and when the shares were acquired.
Does the CXM Form 144 include a representation about inside information?
Yes. The person for whose account the securities are to be sold represents by signing that they do not know of any material adverse information about CXM’s current or prospective operations that has not been publicly disclosed.